Taro Pharmaceutical Industries Ltd.

NYSE:TARO

42.97 (USD) • At close June 21, 2024
Bedrijfsnaam Taro Pharmaceutical Industries Ltd.
Symbool TARO
Munteenheid USD
Prijs 42.975
Beurswaarde 1,615,198,185
Dividendpercentage 0%
52-weken bereik 32.67 - 45.76
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Uday V. Baldota
Website https://www.taro.com

An error occurred while fetching data.

Over Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic

Vergelijkbare Aandelen

Arcus Biosciences, Inc. logo

Arcus Biosciences, Inc.

RCUS

15.5 USD

Avanos Medical, Inc. logo

Avanos Medical, Inc.

AVNS

16.08 USD

Paragon 28, Inc. logo

Paragon 28, Inc.

FNA

10.03 USD

U.S. Physical Therapy, Inc. logo

U.S. Physical Therapy, Inc.

USPH

91.31 USD

Nevro Corp. logo

Nevro Corp.

NVRO

3.79 USD

Cano Health, Inc. logo

Cano Health, Inc.

CANO

2.3 USD

Bright Health Group, Inc. logo

Bright Health Group, Inc.

BHG

16.35 USD

Pediatrix Medical Group, Inc. logo

Pediatrix Medical Group, Inc.

MD

14.09 USD

Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc.

EBS

8.1 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)